The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Coping with antibiotic resistance: combining nanoparticles with antibiotics and other antimicrobial agents
Abstract
The worldwide escalation of bacterial resistance to conventional medical antibiotics is a serious concern for modern medicine. High prevalence of multidrug-resistant bacteria among bacteria-based infections decreases effectiveness of current treatments and causes thousands of deaths. New improvements in present methods and novel strategies are urgently needed to cope with this problem. Owing to their antibacterial activities, metallic nanoparticles represent an effective solution for overcoming bacterial resistance. However, metallic nanoparticles are toxic, which causes restrictions in their use. Recent studies have shown that combining nanoparticles with antibiotics not only reduces the toxicity of both agents towards human cells by decreasing the requirement for high dosages but also enhances their bactericidal properties. Combining antibiotics with nanoparticles also restores their ability to destroy bacteria that have acquired resistance to them. Furthermore, nanoparticles tagged with antibiotics have been shown to increase the concentration of antibiotics at the site of bacterium-antibiotic interaction, and to facilitate binding of antibiotics to bacteria. Likewise, combining nanoparticles with antimicrobial peptides and essential oils generates genuine synergy against bacterial resistance. In this article, we aim to summarize recent studies on interactions between nanoparticles and antibiotics, as well as other antibacterial agents to formulate new prospects for future studies. Based on the promising data that demonstrated the synergistic effects of antimicrobial agents with nanoparticles, we believe that this combination is a potential candidate for more research into treatments for antibiotic-resistant bacteria.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pal, S., Tak, Y. K., & Song, J. M. (2007) · Applied and Environmental Microbiology · doi:10.1128/aem.02218-06 · Cited by 4,040
Drug delivery and nanoparticles: Applications and hazards
de Jong (2008) · International Journal of Nanomedicine · doi:10.2147/ijn.s596 · Cited by 3,848
Lewinski, N., Colvin, V., & Drezek, R. (2008) · Small · doi:10.1002/smll.200700595 · Cited by 2,810
Nanosilver: A nanoproduct in medical application
Chen, X., & Schluesener, H. J. (2008) · Toxicology Letters · doi:10.1016/j.toxlet.2007.10.004 · Cited by 1,888
Antibacterial activity of ZnO nanoparticle suspensions on a broad spectrum of microorganisms
Jones, N., Ray, B., Ranjit, K. T., & Manna, A. C. (2008) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2007.01012.x · Cited by 1,712
Nanosilver as a new generation of nanoproduct in biomedical applications
Chaloupka, K., Malam, Y., & Seifalian, A. M. (2010) · Trends in Biotechnology · doi:10.1016/j.tibtech.2010.07.006 · Cited by 1,451
Fayaz, A. M., Balaji, K., Girilal, M., Yadav, R., Kalaichelvan, P. T., & Venketesan, R. (2010) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2009.04.006 · Cited by 1,417
Shahverdi, A. R., Fakhimi, A., Shahverdi, H. R., & Minaian, S. (2007) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2007.02.001 · Cited by 1,299
The use of microorganisms for the formation of metal nanoparticles and their application
Mandal, D., Bolander, M. E., Mukhopadhyay, D., Sarkar, G., & Mukherjee, P. (2006) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-005-0179-3 · Cited by 1,058
Antioxidant and Anti-Inflammatory Activities of Essential Oils: A Short Review
Miguel, M. G. (2010) · Molecules · doi:10.3390/molecules15129252 · Cited by 933
Kalishwaralal, K., BarathManiKanth, S., Pandian, S. R. K., Deepak, V., & Gurunathan, S. (2010) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2010.04.014 · Cited by 735
Chopra, I. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm006 · Cited by 722
Presenting Vancomycin on Nanoparticles to Enhance Antimicrobial Activities
Gu, H., Ho, P. L., Tong, E., Wang, L., & Xu, B. (2003) · Nano Letters · doi:10.1021/nl034396z · Cited by 703
The forthcoming applications of gold nanoparticles in drug and gene delivery systems
Pissuwan, D., Niidome, T., & Cortie, M. B. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.12.006 · Cited by 669
Zhao, Y., Tian, Y., Cui, Y., Liu, W., Ma, W., & Jiang, X. (2010) · Journal of the American Chemical Society · doi:10.1021/ja1028843 · Cited by 592
Antimicrobial Susceptibility Testing Protocols
(2007) · doi:10.1201/9781420014495 · Cited by 576
Akhavan, O. (2009) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2009.03.018 · Cited by 528
Synergistic antibacterial effects of β-lactam antibiotic combined with silver nanoparticles
Li, P., Li, J., Wu, C., Wu, Q., & Li, J. (2005) · Nanotechnology · doi:10.1088/0957-4484/16/9/082 · Cited by 508
Birla, S. S., Tiwari, V. V., Gade, A. K., Ingle, A. P., Yadav, A. P., & Rai, M. K. (2009) · Letters in Applied Microbiology · doi:10.1111/j.1472-765x.2008.02510.x · Cited by 479
Brunet, L., Lyon, D. Y., Hotze, E. M., Alvarez, P. J. J., & Wiesner, M. R. (2009) · Environmental Science & Technology · doi:10.1021/es803093t · Cited by 469
Biological properties of medicinal plants: a review of their antimicrobial activity
Silva, N., & Fernandes Júnior, A. (2010) · Journal of Venomous Animals and Toxins including Tropical Diseases · doi:10.1590/s1678-91992010000300006 · Cited by 449
Gordon, O., Vig Slenters, T., Brunetto, P. S., Villaruz, A. E., Sturdevant, D. E., Otto, M., Landmann, R., & Fromm, K. M. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01830-09 · Cited by 445
NANOTECHNOLOGY IN MEDICINE AND ANTIBACTERIAL EFFECT OF SILVER NANOPARTICLES
Singh, M., Singh, S., & Prasad, S. R. (2008) · Cited by 348
Acute toxicity of nano- and micro-scale zinc powder in healthy adult mice
Wang, B., Feng, W.-Y., Wang, T.-C., Jia, G., Wang, M., Shi, J.-W., Zhang, F., Zhao, Y.-L., & Chai, Z.-F. (2006) · Toxicology Letters · doi:10.1016/j.toxlet.2005.08.007 · Cited by 307
Comparative study of pulmonary responses to nano- and submicron-sized ferric oxide in rats
Zhu, M.-T., Feng, W.-Y., Wang, B., Wang, T.-C., Gu, Y.-Q., Wang, M., Wang, Y., Ouyang, H., Zhao, Y.-L., & Chai, Z.-F. (2008) · Toxicology · doi:10.1016/j.tox.2008.02.011 · Cited by 276
Reducing infections through nanotechnology and nanoparticles
Webster, T. J., & Taylor (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s22021 · Cited by 267
Antioxidant and antibacterial activities of eugenol and carvacrol‐grafted chitosan nanoparticles
Chen, F., Shi, Z., Neoh, K. G., & Kang, E. T. (2009) · Biotechnology and Bioengineering · doi:10.1002/bit.22363 · Cited by 262
Perni, S., Piccirillo, C., Pratten, J., Prokopovich, P., Chrzanowski, W., Parkin, I. P., & Wilson, M. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2008.09.020 · Cited by 261
Interactions of nanosilver with Escherichia coli cells in planktonic and biofilm cultures
Choi, O., Yu, C.-P., Esteban Fernández, G., & Hu, Z. (2010) · Water Research · doi:10.1016/j.watres.2010.06.069 · Cited by 261
Antibiotic adjuvants: multicomponent anti-infective strategies
Kalan, L., & Wright, G. D. (2011) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399410001766 · Cited by 249
Studies of photokilling of bacteria using titanium dioxide nanoparticles
Tsuang, Y., Sun, J., Huang, Y., Lu, C., Chang, W. H., & Wang, C. (2008) · Artificial Organs · doi:10.1111/j.1525-1594.2007.00530.x · Cited by 247
On the Enhanced Antibacterial Activity of Antibiotics Mixed with Gold Nanoparticles
Burygin, G., Khlebtsov, B., Shantrokha, A., Dykman, L., Bogatyrev, V., & Khlebtsov, N. (2009) · Nanoscale Research Letters · doi:10.1007/s11671-009-9316-8 · Cited by 239
Ruden, S., Hilpert, K., Berditsch, M., Wadhwani, P., & Ulrich, A. S. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01106-08 · Cited by 225
Functionalised gold nanoparticles for controlling pathogenic bacteria
Pissuwan, D., Cortie, C. H., Valenzuela, S. M., & Cortie, M. B. (2010) · Trends in Biotechnology · doi:10.1016/j.tibtech.2009.12.004 · Cited by 221
Methicillin-resistant Staphylococcus aureus: the European landscape
Johnson, A. P. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr076 · Cited by 221
Huang, W., Tsai, P., & Chen, Y. (2009) · Small · doi:10.1002/smll.200801042 · Cited by 198
Kong, H., Song, J., & Jang, J. (2010) · Environmental Science & Technology · doi:10.1021/es1010779 · Cited by 185
Fayaz, A. M., Girilal, M., Mahdy, S. A., Somsundar, S. S., Venkatesan, R., & Kalaichelvan, P. T. (2010) · Process Biochemistry · doi:10.1016/j.procbio.2010.11.001 · Cited by 142
Surface-Enhanced Raman Scattering-Active Nanostructures and Strategies for Bioassays
Jun, B., Kim, G., Noh, M. S., Kang, H., Kim, Y.-K., Cho, M., Jeong, D. H., & Lee, Y. (2011) · Nanomedicine · doi:10.2217/nnm.11.123 · Cited by 142
Borg, M. A., de Kraker, M. E. A., Scicluna, E. A., van de Sande-Bruinsma, N., Tiemersma, E. W., Monen, J., Grundmann, H., & on behalf of the ARMed Project members and collaborators (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm365 · Cited by 139
Preclinical evaluation of novel antibacterial agents by microbiological and molecular techniques
O’Neill, A. J., & Chopra, I. (2004) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.13.8.1045 · Cited by 126
Visible-Light-Induced Bactericidal Activity of Titanium Dioxide Codoped with Nitrogen and Silver
Wu, P., Xie, R., Imlay, K., & Shang, J. K. (2010) · Environmental Science & Technology · doi:10.1021/es101343c · Cited by 125
Chamundeeswari, M., Sobhana, S. S. L., Jacob, S. J. P., Kumar, M. G., Devi, M. P., Sastry, T. P., & Mandal, A. B. (2009) · Biotechnology and Applied Biochemistry · doi:10.1042/ba20090198 · Cited by 118
Nanoconjugated vancomycin: new opportunities for the development of anti-VRSA agents
Chakraborty, S. P., Sahu, S. K., Mahapatra, S. K., Santra, S., Bal, M., Roy, S., & Pramanik, P. (2010) · Nanotechnology · doi:10.1088/0957-4484/21/10/105103 · Cited by 113
Inhibition of methicillin‐resistant Staphylococcus aureus (MRSA) by essential oils
Chao, S. C., Young, G., Oberg, C. J., & Nakaoka, K. (2008) · Flavour and Fragrance Journal · doi:10.1002/ffj.1904 · Cited by 109
Zinn, C. S., Westh, H., Rosdahl, V. T., & Sarisa Study Group (2004) · Microbial Drug Resistance · doi:10.1089/1076629041310055 · Cited by 109
Potential of rosemary oil to be used in drug-resistant infections.
Luqman, S., Dwivedi, G. R., Darokar, M. P., Kalra, A., & Khanuja, S. P. S. (2007) · PubMed · Cited by 90
Amin, R., Mohamed, M. B., Ramadan, M. A., Verwanger, T., & Krammer, B. E. (2009) · Nanomedicine · doi:10.2217/nnm.09.50 · Cited by 82
Maple, P. A. C., Hamilton-Miller, J. M. T., & Brumfitt, W. (1992) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/29.6.661 · Cited by 74
The influence of essential oils on the process of wound healing: a review of the current evidence
Woollard, A., Tatham, K. C., & Barker, S. (2007) · Journal of Wound Care · doi:10.12968/jowc.2007.16.6.27064 · Cited by 71
Rezaei‐Zarchi, S., Javed, A., Ghani, M. J., Soufian, S., Firouzabadi, F. B., Moghaddam, A. B., & Mirjalili, S. H. (2010) · Iranian journal of pathology · Cited by 69
Efflux Pumps and Nosocomial Antibiotic Resistance: A Primer for Hospital Epidemiologists
Weinstein, R. A., & Hooper, D. C. (2005) · Clinical Infectious Diseases · doi:10.1086/430381 · Cited by 62
Trends in Hospitalizations with Antibiotic-Resistant Infections: U.S., 1997–2006
Mainous, A. G., Díaz, V. A., Matheson, E. M., Gregorie, S. H., & Hueston, W. J. (2011) · Public Health Reports · doi:10.1177/003335491112600309 · Cited by 48
Self‐aggregation of water‐soluble chitosan and solubilization of thymol as an antimicrobial agent
Hu, Y., Du, Y., Wang, X., & Feng, T. (2008) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.31871 · Cited by 47
Use of Nanoparticles as Therapy for Methicillin-Resistant Staphylococcus aureus Infections
Liu, P., Lo, C., Chen, C., Hsieh, M., & Huang, C. (2009) · Current Drug Metabolism · doi:10.2174/138920009790274522 · Cited by 34
Methods for Determining Bactericidal Activity and Antimicrobial Interactions
Verma, P. (2007) · CRC Press eBooks · doi:10.1201/9781420014495.ch12 · Cited by 28
Asahara, T., Koseki, H., Tsurumoto, T., Shiraishi, K., Shindo, H., Baba, K., Taoda, H., & Terasaki, N. (2009) · Japanese Journal of Infectious Diseases · doi:10.7883/yoken.jjid.2009.378 · Cited by 22
Biocidal properties of metal oxidenanoparticles and their halogenadducts
Haggstrom, J. A., Klabunde, K. J., & Marchin, G. L. (2009) · Nanoscale · doi:10.1039/b9nr00245f · Cited by 20
Cited by
Antibiotic resistance in microbes: History, mechanisms, therapeutic strategies and future prospects
Uddin, T. M., Chakraborty, A. J., Khusro, A., Zidan, B. R. M., Mitra, S., Emran, T. B., Dhama, K., Ripon, M. K. H., Gajdács, M., Sahibzada, M. U. K., et al. (2021) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2021.10.020 · Cited by 1,311
Antimicrobial Activity of Metal and Metal‐Oxide Based Nanoparticles
Gold, K., Slay, B., Knackstedt, M., & Gaharwar, A. K. (2018) · Advanced Therapeutics · doi:10.1002/adtp.201700033 · Cited by 758
Metal–Organic-Framework-Based Materials for Antimicrobial Applications
Li, R., Chen, T., & Pan, X. (2021) · ACS Nano · doi:10.1021/acsnano.0c09617 · Cited by 555
Shaikh, S., Nazam, N., Rizvi, S. M. D., Ahmad, K., Baig, M. H., Lee, E. J., & Choi, I. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102468 · Cited by 507
Current applications of nanoparticles in infectious diseases
Zazo, H., Colino, C. I., & Lanao, J. M. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.01.008 · Cited by 434
Metadata
- Authors
- Allahverdiyev, A. M., Kon, K. V., Abamor, E. S., Bagirova, M., & Rafailovich, M.
- Venue
- Expert Review of Anti-infective Therapy
- Publisher
- Informa UK Limited
- Published
- 2011-11
- Volume
- 9
- Issue
- 11
- Pages
- 1035-1052
- ISSN
- 1478-7210 (ISSN-L)
- 1744-8336
- OpenAlex
- W2056917379
- Cited by
- 411
- References
- 58
- FWCI
- 4.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.